文献速递儿童呼吸儿童感染

澳大利亚儿童肺炎球菌结合疫苗对肺炎住院有效性的回顾性队列研究

Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
PubMed 文献 · Lancet Child Adolesc Health · 2019-08-19

该研究基于澳大利亚两州行政健康数据,对2001至2012年出生的1 365 893名儿童进行个体记录链接,评估PCV对2岁以下儿童全因肺炎住院的影响。结果显示,2005至2012年PCV普种期与2001至2004年普种前相比,接种和非接种非原住民儿童肺炎住院率均下降,但原住民儿童中仅接种者显著下降;

要点

  • PCV普种期非原住民接种与未接种儿童肺炎住院率均下降,原住民仅接种者显著下降。

核心结论

  • PCV普种期肺炎住院率下降在低发病率的非原住民未接种儿童中更明显,而在高发病率的原住民未接种儿童中不显著。

研究设计与样本

  • 使用Cox模型计算调整风险比,评估PCV剂次对2岁以下儿童肺炎编码住院的影响,随访截止至2013年12月31日。

临床怎么用

  • 在高发病率原住民儿童中,接种PCV与肺炎住院风险降低相关,支持继续推进接种。
  • 使用全因肺炎等非特异性终点评估PCV效果时,在高发病率人群中可能低估疫苗直接保护作用。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reductions in pneumonia hospitalisations following introduction of pneumococcal conjugate vaccines (PCVs) have been reported from high-incidence and low-incidence settings but long-term data comparing vaccinated with unvaccinated children are sparse. METHODS: We did a retrospective, population-based, record-linkage cohort study in Australian children using administrative health data from the Western Australian Midwives' Notification System and New South Wales Perinatal Data Collection, and the birth and death registries in both states. PCV vaccination details, pneumonia-coded hospital admissions, and invasive pneumococcal disease notification records were individually linked for children born between 2001 and 2012. The primary outcome was defined as the first hospital admission for all-cause pneumonia. Cox models were used to calculate adjusted hazard ratios (HR) to estimate the effect of PCV doses on pneumonia-coded hospital admissions by Aboriginal status, birth period, remoteness, and pneumonia diagnostic category in children younger than 2 years. Person-time of follow-up time for each child started at birth and was censored at the earliest of first hospital admission for all-cause pneumonia, death, invalid PCV dose, when the child reached age 24 months, or the end date of the study period (Dec 31, 2013) FINDINGS: The study cohort comprised 1 365 893 children liveborn between Jan 1, 2001, and Dec 31, 2012, of whom 66 484 (4·9%) were identified as Aboriginal. The overall rate for all-cause pneumonia hospital admissions for children younger than 2 years over the entire study period was 17·6/1000 child-years in Aboriginal children and 5·5/1000 child-years in non-Aboriginal children. Compared with children born between 2001 and 2004 (ie, the pre-universal PCV period), the incidence of pneumonia-coded hospital admissions decreased in both vaccinated (6·5 vs 5·7 per 1000 child-years [12% reduction, 95% CI 3-21; p=0·01]) and unvaccinated non-Aboriginal children (6·8 vs 3·7 [45% reduction; 41-49]) born 2005-12 (the universal PCV period); among Aboriginal children, declines were significant only among those vaccinated (27·4 vs 14·1 [49% reduction, 40-55]). Among Aboriginal children born 2005-12, the risk of pneumonia-coded hospital admission after three doses of PCV was lower than those unvaccinated (adjusted HR 0·83, 95% CI 0·65-0·99) but, among non-Aboriginal children, the risk was similar (adjusted HR 1·09, 0·98-1·22). Overall, remote-born Aboriginal children had the highest incidence of hospital admission for pneumonia and among children born 2005-12, the adjusted risk was 37% lower (adjusted HR 0·63, 95% CI 0·42-0·96) among those fully vaccinated than those unvaccinated. INTERPRETATION: Reductions in pneumonia-coded hospital admissions in unvaccinated children predominated in non-Aboriginal children with low incidence of pneumonia but were not significant in Aboriginal children with high incidence. These findings have potential implications for measuring PCV effect using a non-specific endpoint such as all-cause pneumonia in high-incidence populations. FUNDING: Commonwealth Government Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative and the Australian National Health and Medical Research Council.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Fathima P, Gidding HF, McIntyre PB, et al. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study. Lancet Child Adolesc Health. 2019. PMID: 31439496. doi:10.1016/S2352-4642(19)30249-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。